195 related articles for article (PubMed ID: 35241815)
21. An experimental model of anti-PD-1 resistance exhibits activation of TGFß and Notch pathways and is sensitive to local mRNA immunotherapy.
Bernardo M; Tolstykh T; Zhang YA; Bangari DS; Cao H; Heyl KA; Lee JS; Malkova NV; Malley K; Marquez E; Pollard J; Qu H; Roberts E; Ryan S; Singh K; Sun F; Wang E; Bahjat K; Wiederschain D; Wagenaar TR
Oncoimmunology; 2021 Mar; 10(1):1881268. PubMed ID: 33796402
[TBL] [Abstract][Full Text] [Related]
22. Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.
Cazanave SC; Warren AD; Pacula M; Touti F; Zagorska A; Gural N; Huang EK; Sherman S; Cheema M; Ibarra S; Bates J; Billin AN; Liles JT; Budas GR; Breckenridge DG; Tiniakos D; Ratziu V; Daly AK; Govaere O; Anstee QM; Gelrud L; Luther J; Chung RT; Corey KE; Winckler W; Bhatia S; Kwong GA
Sci Transl Med; 2021 Oct; 13(616):eabe8939. PubMed ID: 34669440
[TBL] [Abstract][Full Text] [Related]
23. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
Sun S; Xu L; Zhang X; Pang L; Long Z; Deng C; Zhu J; Zhou S; Wan L; Pang B; Xiao Y
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915876
[TBL] [Abstract][Full Text] [Related]
24. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.
Yang M; Lin C; Wang Y; Chen K; Zhang H; Li W
Genome Med; 2022 Jul; 14(1):72. PubMed ID: 35799269
[TBL] [Abstract][Full Text] [Related]
25. Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling.
Kirkpatrick JD; Warren AD; Soleimany AP; Westcott PMK; Voog JC; Martin-Alonso C; Fleming HE; Tammela T; Jacks T; Bhatia SN
Sci Transl Med; 2020 Apr; 12(537):. PubMed ID: 32238573
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance.
Zhou X; Ni Y; Liang X; Lin Y; An B; He X; Zhao X
Front Immunol; 2022; 13():915094. PubMed ID: 36189283
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer.
Busenhart P; Montalban-Arques A; Katkeviciute E; Morsy Y; Van Passen C; Hering L; Atrott K; Lang S; Garzon JFG; Naschberger E; Hartmann A; Rogler G; Stürzl M; Spalinger MR; Scharl M
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131862
[TBL] [Abstract][Full Text] [Related]
28. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.
Zhu S; Ma AH; Zhu Z; Adib E; Rao T; Li N; Ni K; Chittepu VCSR; Prabhala R; Garisto Risco J; Kwiatkowski D; Mouw K; Sonpavde G; Cheng F; Pan CX
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34725212
[TBL] [Abstract][Full Text] [Related]
30. Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.
Kato R; Haratani K; Hayashi H; Sakai K; Sakai H; Kawakami H; Tanaka K; Takeda M; Yonesaka K; Nishio K; Nakagawa K
Br J Cancer; 2021 Mar; 124(5):914-924. PubMed ID: 33299131
[TBL] [Abstract][Full Text] [Related]
31. Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment.
Zemek RM; De Jong E; Chin WL; Schuster IS; Fear VS; Casey TH; Forbes C; Dart SJ; Leslie C; Zaitouny A; Small M; Boon L; Forrest ARR; Muiri DO; Degli-Esposti MA; Millward MJ; Nowak AK; Lassmann T; Bosco A; Lake RA; Lesterhuis WJ
Sci Transl Med; 2019 Jul; 11(501):. PubMed ID: 31316010
[TBL] [Abstract][Full Text] [Related]
32. Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?
Zhongqi F; Xiaodong S; Yuguo C; Guoyue L
Anticancer Agents Med Chem; 2019; 19(2):222-228. PubMed ID: 30426903
[TBL] [Abstract][Full Text] [Related]
33. Development of a protein-based system for transient epigenetic repression of immune checkpoint molecule and enhancement of antitumour activity of natural killer cells.
Teratake Y; Takashina T; Iijima K; Sakuma T; Yamamoto T; Ishizaka Y
Br J Cancer; 2020 Mar; 122(6):823-834. PubMed ID: 31959920
[TBL] [Abstract][Full Text] [Related]
34. A bioorthogonal system reveals antitumour immune function of pyroptosis.
Wang Q; Wang Y; Ding J; Wang C; Zhou X; Gao W; Huang H; Shao F; Liu Z
Nature; 2020 Mar; 579(7799):421-426. PubMed ID: 32188939
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
36. Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade.
Saida Y; Brender JR; Yamamoto K; Mitchell JB; Krishna MC; Kishimoto S
Cancer Res; 2021 Jul; 81(13):3693-3705. PubMed ID: 33837042
[TBL] [Abstract][Full Text] [Related]
37. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer.
Rech AJ; Dada H; Kotzin JJ; Henao-Mejia J; Minn AJ; Twyman-Saint Victor C; Vonderheide RH
Cancer Res; 2018 Aug; 78(15):4282-4291. PubMed ID: 29844122
[TBL] [Abstract][Full Text] [Related]
39. Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer.
Lu Z; Zou J; Hu Y; Li S; Zhou T; Gong J; Li J; Zhang X; Zhou J; Lu M; Wang X; Peng Z; Qi C; Li Y; Li J; Li Y; Zou J; Du X; Zhang H; Shen L
JAMA Netw Open; 2019 Jul; 2(7):e197621. PubMed ID: 31339548
[TBL] [Abstract][Full Text] [Related]
40. Mutations in
Liu D; Benzaquen J; Morris LGT; Ilié M; Hofman P
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
